Skip to main content
Equibles

FIRST TRUST ADVISORS LP

Position in TBPH — Theravance Biopharma, Inc.

CIK 1125816 Wheaton, IL
Back to TBPH Full portfolio

Position in TBPH

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$316,914
+$9,210 QoQ
Shares Held
18,642
-1.7% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#95
of 179 holders
Holding Since
Mar 2020
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TBPH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FIRST TRUST ADVISORS LP holds $2,844,450,753 across 98 Biotechnology names. TBPH ranks #92 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 547,132 $341,158,687
2 INCY
Incyte Corp
 1,587,996 $180,015,226
3 CORT
Corcept Therapeutics Inc
 1,829,545 $159,078,937
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 289,179 $143,643,884
5 EXEL
Exelixis, Inc.
 2,543,353 $138,383,836
6 ALNY
Alnylam Pharmaceuticals, Inc.
 421,534 $126,894,380
7 KRYS
Krystal Biotech, Inc.
 324,900 $120,755,583
8 AXSM
Axsome Therapeutics, Inc.
 482,061 $117,994,070

All Filings in TBPH

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $316,914 18,642
2026-03-31 $307,704 18,959
2025-12-31 $296,740 15,860
2021-03-31 $623,811 30,564
2020-09-30 $644,744 43,608
2020-06-30 $1,628,509 77,585
2020-03-31 $2,066,403 89,416